E. Liao

Effect of a novel IL-2 cytokine immune agonist (NKTR-214) on proliferating CD8+T cells and PD-1 expression on immune cells in the tumor microenvironment in patients with prior checkpoint therapy.

M. Hurwitz, P. Hwu, M. Tetzlaff, 2017 .